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Abstract
In Brazil, colorectal cancer (CRC) is the fourth most common cause of cancer-related death 
among men, and the third most common among women. We aimed to examine CRC screening-
related knowledge, attitudes, and practices among physicians and nurses working in Brazil’s 
network of health units, and to describe the capacity of these units for CRC screening. In 2011, 
1600 health units were randomly selected from all 26 states and the Federal District. One 
coordinator and one health care provider were selected for the interview. Response rates were 78% 
for coordinators, 34% for physicians, and 65% for nurses. The Brazilian National Cancer Institute 
(INCA) recommendations for CRC screening were not often used in the health units, but screening 
outreach and use of CRC exams were more common in units that were using them. Physicians and 
nurses differed in most characteristics, and in their knowledge, attitudes, and practices of CRC 
screening. Forty-seven percent of physicians reported not conducting CRC screening compared to 
65% of nurses. Fecal occult blood test was most often used by physicians and nurses, but fewer 
physicians than nurses perceived this exam as very effective in reducing CRC mortality. 
Physicians’ gender, years since graduation, and geographical region of practice in Brazil were 
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associated to CRC screening practice. The findings may reflect the low influence of INCA CRC 
screening recommendations, physicians receiving their medical education when CRC burden in 
Brazil was of low concern, and the lack of CRC screening capacity in some regions of Brazil.
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Introduction
In Brazil, colorectal cancer (CRC) is the fourth most common cause of cancer-related death 
among men, and the third most common among women (International Agency for Research 
on Cancer, 2013). In 2012, the age-standardized CRC mortality rate for both sexes was 8.0 
per 100,000 people (International Agency for Research on Cancer, 2013). The Brazilian 
National Cancer Institute (INCA) estimated that over 30,000 new CRC cases were expected 
in 2012, with higher incidence in the South (38 per 100,000) and Southeast regions (45 per 
100,000) compared to the North (9 per 100,000) (Instituto Nacional do Câncer, Ministério 
da Saúde, Brasil, 2011).
Increases in CRC incidence and mortality have been predicted for South American countries 
in the coming years (Center et al., 2009; Jemal et al., 2010). CRC incidence and mortality in 
adults aged 50–75 years can be reduced through screening exams such as a fecal occult 
blood test (FOBT), flexible sigmoidoscopy, or colonoscopy because these tests can detect 
early-stage cancer and precancerous adenomatous polyps (Calonge et al., 2008). Despite 
Brazil’s federally mandated Unified Health System with its network of basic health units, 
which offer comprehensive primary care services, the country does not have a national 
policy or government program that addresses CRC prevention and control (Paim et al., 
2011; Pan-American Health Organization, 2013). Since 2002, INCA has recommended an 
annual FOBT for asymptomatic people aged 50 years or older and colonoscopy in case of a 
positive screening test (Instituto Nacional do Câncer, 2002); however, very little data about 
CRC screening rates are available (Coy, 2013; Perez et al., 2008; Schmidt et al., 2011).
Recommendations from physicians and nurses for patients to participate in CRC cancer 
screening are an important factor in patient CRC screening adherence (Brawarsky et al., 
2004; Khalid-de Bakker et al., 2011; O’Malley et al., 2004; Vernon, 1997). In Brazil, 
knowledge, attitudes, and practices of physicians and nurses regarding CRC screening have 
not been extensively explored, especially by region. The primary aim of this study was to 
explore CRC screening knowledge, attitudes, and practices of physicians and nurses in the 
Brazilian network of health units at a time when the country has a growing CRC burden but 
no national policy or program. Another aim was to describe the capacity of health units for 
CRC screening throughout Brazil.
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In 2011, a telephone survey was administered to health unit coordinators, physicians, nurses, 
and community health workers (CHW) as part of the Guide for Useful Interventions for 
Physical Activity in Brazil and Latin America (GUIA) project. The extensive questionnaire 
included themes related to physical activity, nutrition, and breast, cervical, and colorectal 
cancers. The questionnaire targeting health unit coordinators contained 54 questions, of 
which three were related to CRC. The questionnaire for health care providers had a total of 
79 questions, of which five were related to CRC. Questions were drafted in English, 
translated to Portuguese by native speakers, and back-translated to English. The final 
Portuguese version of the questionnaire was piloted among a small group of participants in 
Brazil. From a list of 42,486 health care units provided by the Ministry of Health, 1600 were 
randomly sampled from all regions of Brazil. The sample was formed by targeting the 
coordinator and the physician in unit 1, the coordinator and the nurse in unit 2, and the 
coordinator and the community health worker in unit 3, so that the total target sample 
included 1600 coordinators, 534 physicians, 533 nurses, and 533 CHWs. If, for example, 
more than one physician worked in unit 1, the interviewer asked the coordinator to provide a 
list with all of them. Of that list, one physician would be sampled using a table with random 
numbers. One coordinator (n = 1600) and one physician (n = 534), nurse (n = 533), or CHW 
(n = 533) were selected from each unit for the interview. Interviews lasted 40 minutes on 
average. We limited our analyses to coordinators, physicians, and nurses’ responses since 
they are responsible for CRC screening activities in Brazil, and CHWs were not asked CRC-
related questions. The overall response rate was 50% across all professional categories (78% 
for coordinators, 34% for physicians, and 65% for nurses). More details about the design 
and sampling methods can be found elsewhere (Florindo et al., 2013; Stormo et al., 2014). 
This study was reviewed and approved by the Research Ethics Committee of the Federal 
University of Pelotas, and the institutional review boards of Washington University in St. 
Louis and the U.S. Centers for Disease Control and Prevention.
Basic health units are formed by multidisciplinary teams of physicians, nurses and nurse 
assistants, and CHWs. Health unit coordinators are responsible for managing the work 
process in the unit, translating national health policies to the unit context, and maintaining 
the connection between these policies, health care providers, and the local population. 
Therefore, they were asked about unit characteristics, use of CRC screening 
recommendations, outreach for CRC screening, and use of CRC exams in the unit 
(Appendix A). Use of CRC screening recommendations and outreach were assessed only if 
coordinators concomitantly knew the INCA recommendations for cancer screening, and 
generally used cancer screening recommendations in the unit.
Physicians and nurses answered questions about use of INCA CRC screening 
recommendations, familiarity with CRC screening exams, perceived exam effectiveness to 
reduce CRC mortality, and use of exams (Appendix B). Knowledge of CRC screening 
methods was determined through questions about familiarity with FOBT and 
sigmoidoscopy. Answers were dichotomized as “more familiar” (“very familiar,” “familiar”) 
and “less familiar” (“little familiarity,” “not familiar”). Attitudes about CRC screening were 
assessed with questions about effectiveness of FOBT, sigmoidoscopy, and colonoscopy, 
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which were re-categorized as “very effective” and “not very effective” (including “little 
effectiveness,” “not effective,” “effectiveness unknown,” “I don’t know”); and perceived 
influence of INCA screening recommendations, for which a binary variable was created 
with responses “very influential” and “not very influential” (“little influential,” “not 
influential,” “I don’t know”). Screening practice was dichotomized as “screening” (“less 
than 50 years,” “50–55 years,” “56–61 years,” “62–67 years,” and “other”) and “no 
screening” (“I do not perform CRC screening”). Physicians and nurses who reported to start 
routine CRC screening for a specific age group were asked about use of FOBT, 
sigmoidoscopy, and colonoscopy in the unit.
Statistical analyses
Descriptive analyses were performed to summarize sample characteristics, health unit 
capacity, and CRC screening knowledge, attitudes, and practices among physicians and 
nurses. Continuous variables were presented as medians with 25th and 75th percentiles, and 
discrete variables as frequencies and percentages. The Pearson chi-square test was used for 
discrete variables. The Wilcoxon rank-sum test was used to test for differences among 
continuous variables. The main response variable analyzed was physicians’ screening 
practices. Bivariate analyses were performed to compare characteristics of physicians who 
screen to those who do not screen. Logistic regression was used to explore which factors 
contribute to physicians not conducting screening. Odds ratios (OR) with 95% confidence 
intervals (95% CI) were reported as an estimate of the magnitude of association. A full 
model was created and backward selection with α = 0.4 used as the significance level for 
maintaining the covariates in the model. Statistical testing in the models was performed 
using Wald chi-square tests. Covariates of interest were age, years since graduation, hours 
working in the unit per week, and patients seen per week, as continuous variables; gender, 
country region, influence of INCA recommendations, familiarity with FOBT exam, and 
perception of FOBT and colonoscopy effectiveness, as categorical variables. The linearity 
assumption for the continuous variables was assessed using restricted cubic spline functions. 
Because there was no evidence of nonlinearity, the continuous variables are presented as 
linear effects in the final model. Robust regression diagnostic methods were employed to 
assess the fit-ness and adequacy of regression models (Hosmer et al., 1991; Kleinbaum et 
al., 1987). Statistical analyses were performed with SAS v.9.3 (Cary, NC).
Results
Unit capacity for CRC screening
Out of 1600 coordinators, 1251 answered the survey. Knowledge of INCA cancer screening 
recommendations in general was reported by 655 coordinators (52%), and of these, 596 
(90%) declared that their unit followed the recommendations. Twenty-five percent of units 
were leading CRC screening outreach activities. FOBT was used in 50% of the units, while 
sigmoidoscopy was used in 17%, and colonoscopy in 26% (data not shown). Thirty-six 
percent (n = 209) reported the use of INCA recommendations for CRC screening in their 
unit (Table 1). In the Central-West Region of Brazil, 41% of units were using INCA 
recommendations for CRC screening, while 36% were using them in the South and 
Northeast, 35% in the Southeast, and 28% in the North. In addition, use of INCA CRC 
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recommendations was 37% among units that covered a population of 5000 people or less; 
29% among those that covered between 5001 and 15,000, and 31% in units covering more 
than 15,000 people. For patients seen per month, 38% of units that received less than 500 
monthly visits used INCA CRC screening recommendations, whereas 33% of those 
receiving between 501 and 1000 visits per month, and 31% of those with over 1000 monthly 
visits used them. However, the differences in use of INCA recommendations for CRC 
screening by region, population covered, or patients seen per month were not statistically 
significant. CRC screening outreach and use of CRC exams were higher (p < 0.001) in units 
using INCA recommendations for CRC screening compared to units that were not using 
them (64% vs. 3% for outreach; 69% vs. 39% for FOBT use; 26% vs. 12% for 
sigmoidoscopy use; and 38% vs. 20% for colonoscopy use).
Provider characteristics and knowledge, attitudes, and practice of CRC screening
A total of 182 physicians and 347 nurses answered the survey. The majority of physicians 
were male, over 30 years old, and had graduated more than 5 years ago (Table 2). Nurses 
were mostly female, 30 years or younger, and had graduated less than 5 years ago. 
Physicians saw more patients per week than nurses (p < 0.001), while nurses more often 
worked 40 hours or more per week compared to physicians (p < 0.001). Regional 
distribution of physicians was similar to that of nurses, most of them practicing in the 
Southeast and Northeast regions.
Forty percent of physicians and 37% of nurses perceived INCA recommendations for CRC 
screening as very influential (p = 0.54). Physicians were more familiar than nurses with 
FOBT (77% vs. 33%; p < 0.001) and with sigmoidoscopy (51% vs. 11%; p < 0.001). In 
addition, more nurses than physicians perceived FOBT (75% vs. 56%; p < 0.001) and 
sigmoidoscopy (92% vs. 82%; p < 0.01) as very effective exams to reduce CRC mortality. 
Colonoscopy was perceived as very effective by 94% of physicians and 97% of nurses (p = 
0.22).
Thirty percent of physicians started routine CRC screening with patients aged 50–55 years 
compared to 14% of nurses (p < 0.001). Sixty-five percent of nurses said they did not 
conduct CRC screening compared to 47% of physicians (p < 0.001). Physicians and nurses 
who were conducting CRC screening identified FOBT as the exam most often used in their 
units (85% and 77%, respectively; p = 0.16) followed by colonoscopy (47% and 58%; p = 
0.14) and sigmoidoscopy (25% and 38%; p = 0.04) (Fig. 1).
Screening practice among physicians
Compared to physicians who were not conducting CRC screening, physicians who were 
conducting it were younger (p < 0.001), had graduated more recently from medical school (p 
< 0.001), were more familiar with FOBT (p = 0.03), and less often perceived FOBT as very 
effective in reducing CRC mortality (p = 0.03; Table 3). After adjusting for gender, years 
since graduation, region, patients seen per week, influence of INCA CRC recommendations, 
and perception of FOBT effectiveness (Table 4), female physicians (OR 2.18, 95% CI 1.07–
4.42), and those practicing in the North compared to the South (OR 5.99, 95% CI 1.10–
32.67), were more likely to not conduct screening. The more years since medical school 
Puricelli Perin et al. Page 5













graduation, the less likely physicians said they would screen for colorectal cancer, with odds 
of not screening increasing by 1.37 (95% CI 1.17–1.60) for each 5-year increase in years 
since graduation.
Discussion
Unit capacity for CRC screening is still low in Brazil. This finding is further supported by a 
recent assessment of CRC programs globally which found a general lack of infrastructure 
for CRC screening in South American countries even though national CRC screening 
guidelines may be in place (Schreuders et al., 2015). CRC screening outreach activities were 
not common in Brazilian health units and use of CRC screening exams was infrequent, 
especially for sigmoidoscopy and colonoscopy. However, units using INCA CRC screening 
recommendations had higher use of FOBT, sigmoidoscopy, and colonoscopy, and more 
screening outreach.
Our study revealed that approximately half of surveyed physicians in Brazil were screening 
their eligible patients for CRC. Only 30% were routinely starting screening with patients 
aged 50–55 years, reinforcing our findings that INCA recommendations for CRC screening 
were not often used in the units and that their influence among physicians was low. 
Regarding the method of screening, physicians were fairly familiar with FOBT and 
sigmoidoscopy, and almost all of them perceived colonoscopy as being very effective in 
reducing CRC mortality. Physicians were less certain, however, about the effectiveness of 
FOBT. Although colonoscopy has been shown to reduce CRC mortality (Zauber et al., 
2012), its effectiveness has not been verified in randomized controlled trials (RCT), and the 
quality of the evidence is fair (Calonge et al., 2008; Lieberman et al., 2012; National Cancer 
Institute; U.S. Preventive Services Task Force, 2008). The magnitude of FOBT effectiveness 
in reducing CRC mortality may be smaller than that of colonoscopy, but it has been assessed 
through good-quality RCTs (National Cancer Institute; Pignone et al., 2002). FOBT and 
other similarly less invasive tests could play a fundamental role in reaching more people 
because of better acceptability (Benson et al., 2008; Hardcastle et al., 1996; Multicentre 
Australian Colorectal-neoplasia Screening Group, 2006; Segnan et al., 2005). In Thailand, 
where 62% of primary care physicians routinely recommend CRC screening to 
asymptomatic average-risk patients (Thanapirom et al., 2012), results of a pilot 
implementation program using fecal immunochemical tests (FIT) demonstrated the 
possibility of screening a large number of people without straining the health system, and 
considerably reducing the need for more complex exams, such as sigmoidoscopy and 
colonoscopy (Khuhaprema et al., 2014). This may be particularly beneficial to Brazil, where 
health units might adequately offer a secondary prevention service of lower complexity, 
increasing the breadth of their services and expanding their capacity for cancer control.
Nurses were not very familiar with FOBT and sigmoidoscopy, but most considered all CRC 
exams very effective in reducing CRC mortality. However, the majority of nurses did not 
conduct CRC screening, an expected result since the initiation of a screening routine is the 
responsibility of physicians in Brazil. It is important to note that we were not able to 
distinguish if nurses who reported starting routing CRC screening were doing it directly or 
simply recommending that the patient talked to his or her physician. The pilot study in 
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Thailand illustrates the opportunity of engaging nurses, and also CHWs, in CRC screening 
by training patients for successful collection of FIT stool samples and other outreach 
activities (Khuhaprema et al., 2014). Similar engagement could be promoted in Brazil via 
the Unified Health System and its health units.
Overall, our findings were not surprising since Brazil does not have CRC screening 
programs or a national policy to guide CRC prevention and control. Cancer prevention and 
control in Brazil regained strength in the 1990s when the newly created Unified Health 
System was being structured (Parada et al., 2008). INCA was then in charge of developing 
national cancer policies, which included the creation of the first national program for 
cervical cancer control, in 1998 (Instituto Nacional do Câncer, Ministério da Saúde, Brasil, 
2010). More recently, the Brazilian Ministry of Health has taken the lead in program 
development with the introduction of a national policy for the prevention and early detection 
of breast and cervical cancers in 2008 (Presidência da República, Casa Civil, Brasil, 2008) 
and in 2012 with the creation of a national plan to direct resources to cancer prevention and 
control (Presidência da República, Casa Civil, Brasil, 2012). Of note, the survey was 
conducted in the public sector’s network of primary health units. They form an important 
part of the Brazilian health system: public health units were reported as the usual source of 
care for 57% of the population in 2008, and the public sector employs over half of the health 
care force in Brazil (Paim et al., 2011). Yet the private health care sector is responsible for 
62% of hospital care, 92% of tertiary diagnostic health services, and at least 20% of 
ambulatory care in Brazil (Santos et al., 2008). Differences in knowledge, attitudes, and 
practice of CRC screening may exist among physicians and nurses practicing in public 
versus private sector. Souza et al. did not find differences between physicians’ source of 
income (public, private, or both) and their knowledge and practice of CRC screening; 
however, the study had a small sample size and was based in one hospital (Souza et al., 
2012). National provider-based studies analyzing possible differences between sectors are 
needed in order to understand the full picture of CRC screening in the Brazilian health 
system.
Given that, in Brazil, CRC may not be as high a priority as other cancers (Coy, 2013; 
Secretaria Municipal da Saúde de São Paulo-Coordenação de Epidemiologia e Informação 
(SMS/SP). Boletim CEInfo Análise n°06. São Paulo: SMS/SP, 2012), the low number of 
physicians conducting CRC screening was expected. Physicians less likely to conduct CRC 
screening were women, physicians who graduated longer ago from medical school, and 
those who were practicing in the North compared to the South. The last comparison is 
especially important since access to health care has been historically dependent on 
socioeconomic and geographic characteristics in Brazil. Although efforts have been made in 
the past decades to accelerate the development of North, Northeast, and Center-West 
regions, these are traditionally poorer and with less health infrastructure compared to the 
South and Southeast (Paim et al., 2011). In addition, the Brazilian health system faces 
challenges related to lack of CRC awareness in the population and the high costs of exams 
(Dias et al., 2007). Female physicians usually offer more preventive counseling and 
screening recommendations than male physicians (Henderson and Weisman, 2001). Based 
on our survey results, we were not able to explain the lower screening practice among 
female physicians, and that should be further investigated. Supporting our finding that lack 
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of CRC screening increases with number of years since graduation, a study done in Southern 
Brazil revealed that physicians who graduated more than 15 years ago were less aware of 
CRC screening recommendations than the ones who graduated more recently (Souza et al., 
2012). This is possibly due to the relatively recent introduction in Brazil of INCA 
recommendations for CRC screening in 2002. Before, physicians followed international 
recommendations, such as the ones provided by the American Cancer Society, and their 
influence in CRC screening practice has been similarly low (Secretaria Municipal da Saúde 
de São Paulo-Coordenação de Epidemiologia e Informação (SMS/SP). Boletim CEInfo 
Análise n°06. São Paulo: SMS/SP, 2012; da Silva et al., 2011; Tucunduva et al., 2004).
Study limitations
Limitations of our study include the low response rate among physicians, which may have 
biased our estimates. Adherence to INCA-recommended age of CRC screening initiation 
could not be analyzed because of the small number of observations among physicians 
available for subgroup analyses. In addition, self-report may have allowed physicians, 
nurses, and coordinators to give answers that would be expected and acceptable by their 
supervisors, instead of their actual practice or knowledge. Study strengths included the 
random assessment of units throughout all regions, even in more remote municipalities, 
which may offer a representative picture of the Brazilian public health system. Moreover, 
the prediction model for screening practice allowed for better insights on why physicians 
may not screen for CRC.
Conclusion
Latin–American countries are moving toward prioritizing cancer prevention and control but 
often lack policy and programs that address CRC specifically. Brazil has the potential to be 
a leading example in the region, drawing upon examples of pilot CRC screening programs 
available abroad (Khuhaprema et al., 2014; Seeff and Rohan, 2013), and in-country (Perez et 
al., 2008).
Our study aimed to understand current CRC screening knowledge, attitudes, and practices of 
providers in the Brazilian network of health units. INCA currently recommends annual 
FOBT exams for asymptomatic people age 50 or older and a colonoscopy in case of a 
positive result, but its influence in the screening practice of physicians is limited. The 
majority of physicians and nurses are aware of the effectiveness of CRC screening in 
reducing mortality, and physicians are more often familiar with CRC exams. However, 
almost half of physicians did not conduct CRC screening, which may reflect the low 
influence of screening recommendations, physicians receiving their medical education when 
CRC was not of high concern in Brazil, lack of capacity for CRC screening in certain parts 
of the country, and lack of national or local CRC screening programs. Given the increasing 
burden of colorectal cancer, this baseline information might be useful for Brazil.
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Appendix A. Survey questions related to colorectal cancer screening for 
coordinators; GUIA, 2011, Brazil
Possible answers
Knowledge of INCA cancer screening recommendations
1. Do you know the INCA recommendations for cancer screening? (0) No (Skip to question 5)
(1) Yes
(9) I don’t know/ N/A
2. Does your unit follow the INCA recommendations for cancer screening? (0) No (Skip to question 5)
(1) Yes
(9) I don’t know/ N/A







(9) I don’t know
Cancer screening outreach






(9) I don’t know
Use of CRC screening exams
5. What colorectal cancer screening methods are used in your unit with asymptomatic 
patients?





(9) I don’t know
CRC: colorectal cancer; INCA: Brazilian National Cancer Institute
Appendix B. Survey questions related to colorectal cancer screening for 
physicians and nurses; GUIA, 2011, Brazil
Possible answers
Perception of CRC screening effectiveness
1. How effective do you believe the following methods are to 
reduce colorectal cancer mortality?







(9) I don’t know
Perception of influence of INCA recommendations
2. INCA released recommendations about colorectal cancer 
screening. In your unit, would you say the recommendations for 




(4) I don’t know
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Familiarity with CRC screening exams
3. For each of the following exams, please indicate how familiar 
you are with:






CRC screening practice and adherence with recommendations





(6) I don’t do colorectal cancer screening (Ends 
the interview)
5. Which of the following screening exams are used in your unit to 
screen patients?






CRC: colorectal cancer; INCA: Brazilian National Cancer Institute
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Use of colorectal cancer screening exams by provider type in Brazil; GUIA 2011.a. aOnly 
providers who self-reported performing CRC screening were asked the question—53% of 
physicians (n = 92); 35% of nurses (n = 119). Error bars represent 95% confldence intervals. 
FOBT: fecal occult blood test.
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